Anatoly Garelik has been with Anellotech since 2010. He has played a major role in securing financing for the company’s technology development program including participating in negotiation of Anellotech’s major partnerships and investments and overseeing investor due diligence. Anatoly is also responsible for strategic financial planning. Prior to Anellotech, he was a Vice President at Citigroup managing IT infrastructure for the Alternative Investments business. Anatoly earned an MBA with distinction from NYU Stern School of Business and an M.S. in Information Systems.

David Sudolsky has led Anellotech since its founding in 2008. He has secured over $100 million in strategic partner funding as Anellotech completed development of the Bio-TCat Process (non-food biomass to BTX) and is now pioneering the Plas-TCat Process (chemical recycling of mixed plastics to BTX and light olefins). Prior to joining Anellotech, David was a business officer or CEO of five biotechnology, specialty pharmaceutical and bioprocessing start-ups, one of which (Dura Pharmaceuticals) was sold for $1.8 billion.